37.3
[]. D B Buxton, et al. The effects of cyclopropane carboxylic acid on hepatic pyruvate metabolism. Metabolism. 93 Jul;32(7):736-44.
[2]. H M Badawi, et al. Potential energy scans and vibrational assignments of cyclopropanecarboxylic acid and cyclopropanecarboxamide. Spectrochim Acta A Mol Biomol Spectrosc. 200 Dec 5;7(4):540-6.
[3]. Masayuki Wasa, et al. Pd(II)-catalyzed enantioselective C-H activation of cyclopropanes. J Am Chem Soc. 20 Dec 4;33(49):959-60.
[4]. Orazio Prezzavento, et al. A new sigma ligand, (+/-)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect. Life Sci. 200 Mar 2;2(-2):549-53.
[5]. Steven Lacy, et al. Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites. Drug Metab Dispos. 205 Aug;43():90-207.
H227-H34
P260-P264-P20-P30+P330+P33-P303+P36+P353-P304+P340-P305+P35+P33-P363-P405-P50